Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells.
Qin Y, Cui Q, Sun G, Chao J, Wang C, Chen X, Ye P, Zhou T, Jeyachandran AV, Sun O, Liu W, Yao S, Palmer C, Liu X, Arumugaswami V, Chan WC, Wang X, Shi Y.
Qin Y, et al. Among authors: wang x, wang c.
Cell Rep. 2024 Oct 19:114867. doi: 10.1016/j.celrep.2024.114867. Online ahead of print.
Cell Rep. 2024.
PMID: 39447568
Free article.